Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence abbvie.com ↗
2026-06-24
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 abbvie.com ↗
2026-04-08
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year abbvie.com ↗
2025-10-29
AbbVie
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year abbvie.com ↗
2025-10-06
AbbVie
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor abbvie.com ↗
2025-09-09
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories abbvie.com ↗
2024-11-07
AbbVie
Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day abbvie.com ↗
2024-10-18
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands) abbvie.com ↗
2024-09-24
AbbVie
Empowering Women Entrepreneurs: 2024 BOTOX® (onabotulinumtoxinA) Cosmetic Grant Recipients Kick Off Crowdfunding Campaigns abbvie.com ↗
2024-09-11
AbbVie
Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China abbvie.com ↗
2024-06-11
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients abbvie.com ↗
2024-04-23
AbbVie
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands abbvie.com ↗
2024-02-21
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women Entrepreneurs abbvie.com ↗
2023-11-20
AbbVie
Fifth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Makes History as the Biggest Day Ever abbvie.com ↗
2023-11-01
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before abbvie.com ↗
2023-09-18
AbbVie
Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX® Cosmetic) for the Treatment of Platysma Prominence abbvie.com ↗
2023-09-06
AbbVie
Join BOTOX® Cosmetic (onabotulinumtoxinA) and IFundWomen in Supporting Women Entrepreneurs abbvie.com ↗
2023-08-30
AbbVie
Journal of Cosmetic Dermatology Publishes Data Demonstrating Patient Satisfaction with Natural-Looking Outcomes Following Treatment with OnabotulinumtoxinA (BOTOX® Cosmetic) abbvie.com ↗
2023-06-13
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Announces the Winners of the IFundWomen Grant Program abbvie.com ↗
2023-03-08
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs abbvie.com ↗
2022-11-17
AbbVie
Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Most Successful One Yet abbvie.com ↗
Allergan Aesthetics and BOTOX® Cosmetic (OnabotulinumtoxinA) Reveal New 'See Yourself' Campaign Cast, Spotlighting 25 Real People and Their Stories abbvie.com ↗
2022-04-13
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval abbvie.com ↗
2022-01-24
AbbVie
Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA) abbvie.com ↗
2021-11-15
AbbVie
Allergan Aesthetics Celebrates Third Annual BOTOX® Cosmetic (onabotulinumtoxina) Day abbvie.com ↗
2021-07-29
AbbVie
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity abbvie.com ↗
2021-06-08
AbbVie
Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign abbvie.com ↗
2021-02-10
AbbVie
BOTOX® (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition abbvie.com ↗
2020-11-16
AbbVie
Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day abbvie.com ↗
2020-07-09
AbbVie
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity abbvie.com ↗
2020-06-22
AbbVie
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity abbvie.com ↗
2019-06-21
AbbVie
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity abbvie.com ↗
2019-03-07
AbbVie
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity abbvie.com ↗
2019-01-28
AbbVie
New BOTOX® Cosmetic (onabotulinumtoxinA) "Own Your Look" Campaign Brings Fresh Face To Trusted Brand abbvie.com ↗
2018-09-14
AbbVie
Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxinA) for the Treatment of Moderate to Severe Glabellar Lines abbvie.com ↗
Evidence & citations 3 cited values
Every value below carries the sentence it was read from.
2 sources stand behind the page.
Field
Value
Cited text
Known as
Botulinic toxin
ClinicalTrials.gov intervention name — accepted as the source's own labelNCT00199589 ↗1